Últimas notícias Coronavac

As vacinas seguem agora para o Controle de Qualidade interno de Bio-Manguinhos, onde uma análise minuciosa irá garantir a sua integridade e segurança (foto: Bio-Manguinhos/Fiocruz)
Health

Covid-19: all vaccines administered in Brazil are effective

The information is contained in the first edition of the bulletin on the effectiveness of vaccines against covid-19 in the Brazilian population, from the Vigivac project by Fiocruz, published on the 9th.

Chegada de 59.800 doses da vacina CoronaVac (17.03.2021)
Foto: Breno Esaki/Agência Saúde DF
Fachada,Instituto Butantan
Health

Butantan Institute starts producing its vaccine against COVID-19

ButanVac will be produced at the Butantan factory where flu vaccines are made—a production that has already come to an end this year. ButanVac will be fully manufactured in São Paulo, with no imported supplies necessary.

Vacina, frascos contendo CoronaVac, vacina da Sinovac contra coronavírus
Health

Butantan delivers another 5 mi doses of CoronaVac to Brazil

In March, 19.3 million doses have been delivered. By the end of April, the total amount of vaccines provided by Butantan will have reached 46 million.

Caixas com vacinas experimentais contra Covid-19 da Sinovac em Pequim. coronavac
Health

Studies show CoronaVac efficient against three coronavirus variants

It is efficient against the British B.1.1.7, the South African B.1.351, and Brazil’s B.1.1.28, of which are derived variants P.1, from Manaus, and P.2, from Rio de Janeiro.